Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] The Tradeoffs Involved in New Drug Approval, Expanded Access, and Right to Try

Posted on: March 23, 2020May 13, 2026Healthcare , Pharma

The following post comes from CPIP Senior Fellow for Life Sciences Erika Lietzan, and it is cross-posted here from the Objective Intent blog with permission. This note explains some of […]

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes